Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Open-label Trial to Assess the Safety and Efficacy of Switching to Tenofovir-emtricitabine or Abacavir-lamivudine: The STEAL Study.

NCT00192634 is registered in ClinicalTrials.gov with Kirby Institute as lead sponsor.

NCT NCT00192634
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00192634 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Open-label Trial to Assess the Safety and Efficacy of Switching to Tenofovir-emtricitabine or Abacavir-lamivudine: The STEAL Study.
Lead sponsor
Kirby Institute
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2005
Completion date
August 31, 2008
Enrollment
357 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections